# Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients

> **NCT03469063** · NA · UNKNOWN · sponsor: **Barretos Cancer Hospital** · enrollment: 104 (estimated)

## Conditions studied

- Quality of Life
- Infection
- Drug Toxicity

## Interventions

- **DIETARY_SUPPLEMENT:** AferBio

## Key facts

- **NCT ID:** NCT03469063
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-28
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-06-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2018-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469063, "Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03469063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*